Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. J of Skin. 2024;8(1):s320. doi:10.25251/skin.8.supp.320